Ventas, Inc. (NYSE:VTR) Announces $0.52 Quarterly Dividend

Key Points

• Ventas declared a quarterly dividend of $0.52 per share, payable October 15 to shareholders of record September 30. The dividend implies an annualized payout of $2.08 and a 2.3% yield.
• The current 270.1% earnings-based payout ratio indicates the dividend is not covered by present earnings, although analysts expect next year’s earnings to reduce the projected payout ratio to 48.5%.
• Ventas reported quarterly revenue of $1.73 billion and EPS of $0.97, both exceeding estimates, while analysts maintain a “Moderate Buy” consensus with an average price target of $99.

Ventas, Inc. (NYSE:VTR - Get Free Report) declared a quarterly dividend on Monday, September 14th. Investors of record on Wednesday, September 30th will be paid a dividend of 0.52 per share by the real estate investment trust on Thursday, October 15th. This represents a c) dividend on an annualized basis and a yield of 2.3%. The ex-dividend date of this dividend is Wednesday, September 30th.

Ventas has decreased its dividend by an average of 0.0%per year over the last three years and has raised its dividend every year for the last 1 years. Ventas has a dividend payout ratio of 270.1% meaning the company cannot currently cover its dividend with earnings alone and is relying on its balance sheet to cover its dividend payments. Equities analysts expect Ventas to earn $4.29 per share next year, which means the company should continue to be able to cover its $2.08 annual dividend with an expected future payout ratio of 48.5%.

Ventas Trading Down 1.0%

Shares of VTR stock opened at $89.12 on Tuesday. The business's fifty day moving average price is $92.83 and its 200 day moving average price is $88.00. The firm has a market capitalization of $45.71 billion, a PE ratio of 165.03, a P/E/G ratio of 3.51 and a beta of 0.70. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.44 and a quick ratio of 0.44. Ventas has a 1-year low of $66.54 and a 1-year high of $101.60.

Ventas (NYSE:VTR - Get Free Report) last issued its earnings results on Wednesday, July 29th. The real estate investment trust reported $0.97 EPS for the quarter, topping the consensus estimate of $0.96 by $0.01. Ventas had a net margin of 4.08% and a return on equity of 1.99%. The company had revenue of $1.73 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same period in the previous year, the firm earned $0.87 EPS. The business's revenue was up 21.7% on a year-over-year basis. As a group, sell-side analysts forecast that Ventas will post 3.89 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the company. Scotiabank upped their price target on Ventas from $93.00 to $95.00 and gave the stock a "sector perform" rating in a report on Wednesday, September 2nd. Raymond James Financial began coverage on Ventas in a report on Tuesday, June 16th. They set an "outperform" rating and a $94.00 price objective for the company. Mizuho boosted their target price on Ventas from $98.00 to $104.00 and gave the stock an "outperform" rating in a research report on Wednesday, July 22nd. Royal Bank Of Canada upped their target price on Ventas from $98.00 to $99.00 and gave the company an "outperform" rating in a report on Friday, August 14th. Finally, The Goldman Sachs Group restated a "buy" rating and issued a $110.00 price target on shares of Ventas in a research report on Tuesday, May 19th. Fourteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Ventas currently has an average rating of "Moderate Buy" and a consensus target price of $99.00.

About Ventas

Ventas, Inc is a real estate investment trust (REIT) that owns and manages a diversified portfolio of healthcare and senior living properties. Its real estate platform includes senior housing communities, medical office buildings, life science and innovation centers, and other healthcare-related facilities.

The company generally leases or operates its properties through relationships with healthcare providers, senior living operators, universities, and research institutions. Its properties support services such as independent and assisted living, skilled nursing, outpatient care, physician practices, medical research, and biotechnology development.

Ventas serves major healthcare and life science markets in the United States and Canada.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.